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Endoaortic stent grafting of a giant infected
hepatic-celiac pseudoaneurysm
Lefeng Qu, MD, PhD, Zaiping Jing, MD, PhD, and Rui Feng, MD, PhD, Shanghai, People’s Republic of
China
A 72-year-old man was admitted because of progressive right upper-abdominal distension and pain as well as concurrent
remittent fever for 5 months. He had undergone a radical gastrectomy and catheter intubation in the common hepatic
artery for chemotherapy 12 months before admission. The diagnosis of giant infected hepatic-celiac artery pseudoaneu-
rysm was established. Coils embolotherapy was given in another hospital, but it failed. After admission, a computed
tomographic aortogram showed a mass 10.3 8.5 8.1 cm in size in the right upper abdomen that originated from the
common hepatic artery and the celiac artery. A celiac-super mesenteric artery (SMA) double catheter simultaneous digital
subtraction angiography (DSA) further revealed that the entrance of the aneurysm opened directly from the abdominal
aorta, the distance between the orifice of SMA and celiac axis was only 0.5 cm, and the diameter of the celiac trunk had
been aneurysmally enlarged to 2.0 cm. A blood culture was positive for Bacillus pyocyaneus. After detailed discussion and
preparation, a stent-graft complex was negotiated through the left femoral artery and deployed successfully into the
abdominal aorta to seal the orifice of celiac trunk under the dynamic supervision of DSA. Completion angiography
revealed that the hepatic-celiac pseudoaneurysm was completely excluded from aortic flow by the endoluminal stent-graft
complex, while the SMA and renal arteries remained perfectly patent. The patient recovered uneventfully and was
discharged without any residual symptoms. At a 5-year follow-up, the patient remained asymptomatic and was leading a
normal life. ( J Vasc Surg 2005;42:159-62.)Compared with aortic aneurysms and peripheral arte-
rial aneurysms, visceral aneurysms have a lower incidence.
Hepatic arterial aneurysms (HAAs) and celiac arterial aneu-
rysms (CAAs) account for 16%1 and 4%,2 respectively, of all
visceral aneurysms. Less reported is the hepatic-celiac artery
aneurysm that involves both the hepatic artery and the
celiac artery. We did an English language search of the
MEDLINE literature for the term infected hepatic-celiac
pseudoaneurysm and found no report until December 31,
2004. Here we report a case of a giant infected hepatic-
celiac artery pseudoaneurysm treated with placement of a
stent graft in the abdominal aorta.
CASE REPORT
A 72-year-old Chinese man was admitted on August 16,
1999, because of a chief complaint of right upper abdominal
distention and vague pain, as well as concurrent remittent fever for
5 months. He had undergone a radical gastrectomy and placement
of a chemotherapy port through intubation of the common he-
patic artery for gastric cancer 12 months before admission. Seven
months after the gastrectomy, the patient was admitted to another
comprehensive hospital where the diagnosis of an infected com-
mon hepatic artery pseudoaneurysm was established, and he was
referred for coils embolotherapy through the celiac artery. Because
the opening orifice of the celiac artery (the entrance of the aneu-
rysm) had aneurysmally enlarged to 2.0 cm, the endovascular
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50-pack-year history of smoking.
On physical examination, the patient presented in a depleted
condition. His temperature fluctuated from 36.6°C to 40.2°C
every afternoon. The right upper abdomen was distended, with a
slight tenderness. Laboratory tests revealed an elevated leukocyte
count (white blood cells, 12.2  109/L, N 82%), slight anemia
(hemoglobin, 112g/L) and a reversed albumin/globulin ratio of
0.8. A blood culture was positive for Bacillus pyocyaneus.
A contrast-enhanced computed tomographic aortogram
(CTA) showed a mass 10.3  8.5 8.1 cm in size in the right
upper abdomen that originated from the common hepatic artery
and the celiac artery (Fig 1). A celiac-superior mesenteric artery
(SMA) double catheter, simultaneous digital subtraction an-
giography (DSA) further revealed that the entrance of the
aneurysm, with several metallic coils vigorously moving inside,
opened directly from the abdominal aorta, the distance between
the SMA orifice and celiac axis was only 0.5 cm, and the
diameter of the celiac trunk had been aneurysmally enlarged to
2.0 cm (Fig 2).
After admission, the patient had been given wide-spectrum
antibiotic therapy and parenteral nutrition support until the oper-
ation, which did little to improve his condition. On the contrary,
abdominal pain became more severe. Considering his poor general
condition, endovascular stent-graft exclusion (EVSGE) came to be
the first choice for treatment.
Under general anesthesia, the left femoral artery was exposed
through a groin incision. Then, under the dynamic supervision of
DSA, a Talent stent-graft complex (40mm in length and 29mm in
diameter) (Medtronic, Minneapolis, MN) was negotiated and
deployed successfully in the abdominal aorta to seal the orifice of
the celiac trunk on September 2, 1999.
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cialized stent-graft complex, which was usually deployed first in the
targeted lumen, the stent-graft complex was reassembled to make
the markers reverse on the table, thus the markers could dominate
the orifice of the SMA. After deployment in the air, the stent graft
was reversed and placed around the core of the sheath in its original
position. The end of the stent graft was then constricted with a
thread, the thread moved distally, and the stent-graft was con-
stricted gradually. While constricting, the outer sheath was moved
forward, and the stent graft was gradually reloaded into the sheath.
A completion angiogram revealed that the hepatic-celiac pseu-
Fig 1. A contrast-enhanced computed tomographic aortogram
showed a 10.3 8.5 8.1-cm sizemass (arrow) in the right upper
abdomen that originated from the common hepatic artery and the
celiac artery.
Fig 2. Double catheter simultaneous digital subtraction angiog-
raphy revealed that the entrance of the aneurysm opened directly
from the abdominal aorta (top arrow), the distance between the
orifice of superior mesenteric artery and celiac axis was only 0.5 cm
(bottom arrow), and the diameter of the celiac trunk had been
aneurysmally enlarged to 2.0 cm (top arrow).doaneurysm was completely excluded from the aortic flow by theendoluminal stent-graft complex, while the SMA and renal arteries
remained perfectly patent (Fig 3).
After EVSGE, the patient received intravenous antibiotic ther-
apy for 1 week, and within several days his temperature dropped to
normal range. No signs of visceral ischemia were noted, and the
laboratory test results returned to normal. CTA on postoperative
day 25 revealed that the endovascular implant was patent, without
any migration or torsion, the aneurysm was full of thrombi, and no
endoleak was evident (Fig. 4).
The patient recovered uneventfully and was discharged with-
out any residual symptoms. At a 5-year follow-up, the patient
remained asymptomatic and was leading a normal life. CTA scan
showed the disappearance of the giant pseudoaneurysm and no
evidence of endoleak (Fig 5).
DISCUSSION
Most etiologies of HAA and CAA are atherosclerosis
(32%), trauma (22%), and inflammatory lesions (10%),3-5
sometimes iatrogenic. The etiology of our patient is the
latter. Although patients are often asymptomatic at the
early stage, the risk of rupture is high. Rupture or perfora-
tion of the aneurysms is the first clinical presentation in 60%
to 80% of patients, with a high mortality rate and fatal
outcome.3 With modern diagnostic technology, the aneu-
rysms can be identified before rupture and fatal hemor-
rhage, which provides the opportunity for intervention.
Obviously, it is really tough work to expose and remove
this giant infected pseudoaneurysm in a postoperative high-
risk patient. We were facing such high risks as massive
intra-operative hemorrhage and postoperative fatal mor-
bidity and mortality; therefore, conventional surgery was
excluded after a brief discussion. Accordingly, these risks
may be reduced or even avoided if a minimally invasive
endovascular approach such as selective embolotherapy or
Fig 3. A completion angiogram revealed that the hepatic-celiac
pseudoaneurysm was completely excluded from aortic flow by the
endoluminal stent-graft, while the superior mesenteric artery (top
arrow) and the bilateral renal arteries (bottom arrows) remained
perfectly patent.EVSGE is employed.6-8
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materials had proved ineffective for this patient in another
hospital because of the great diameter of the aneurysmal
orifice and the giant volume of the aneurysm sac. So we
came to consider a new technique in vascular surgery,
EVSGE.
During the past decade, EVSGE has become increas-
ingly acceptable in vascular surgery fields all over the world.
It has been used to treat aortic atherosclerotic and dissect-
ing aneurysms,9,10 peripheral arterial false aneurysms, and
arteriovenous fistulas11,12 among others, but there have
been no reports of this technique being applied to an
infected hepatic-celiac arterial pseudoaneurysm. However,
Fig 4. A computed tomographic aortogram on postoperative day
25 revealed that the aneurysm was full of thrombi (arrow) and no
evidence of endoleak.
Fig 5. A 5-year follow up computed tomographic aortogram
showed disappearance of the giant pseudoaneurysm and no evi-
dence of endoleak.this tough lesion was resolved by covering the orifice of thegiant aneurysm, which involved the abdominal aorta, by
placement of a stent graft in the abdominal aorta.
It is, however, quite controversial to seal the orifice of
the celiac trunk because of the possibility of visceral isch-
emia. Before proceeding with endovascular exclusion, we
believed that there was a minimal possibility of visceral
organs ischemia in this patient. This was because the left
gastric artery had been ligated and resected in the previous
radical gastrectomy, the distal end of hepatic artery had
been occluded by the prior coil embolotherapy, and the
massive aneurysm had been compressing on the hepatic and
splenic arteries for long time. All of these factors contrib-
uted to the opening and formation of visceral collateral
circulations from SMA, esophageal and diaphragmatic ar-
teries, and portal veins, among others. Of course, the
collateral circulations can protect in the liver, residual stom-
ach, spleen, and pancreas from ischemia after abdominal
aortic exclusion. And actually, we did not find that much
contrast filled the aneurysm retrogradely in short time in
the selective SMA arteriogram, and this contributed to the
thrombosis of the aneurysm after exclusion.
In this case, another tough problem was that SMA
blood supply must be preserved while the celiac trunk is
completely excluded from aorta. To solve this problem, we
carefully took the following measures:
First, the relative parameters of the giant pseudoaneu-
rysm, such as the size of the aneurysm, the orifice diameter
of the aneurysm, the distance between the orifices of celiac
axis and SMA, the diameter of the abdominal aorta in the
lesion level, and the location of bilateral renal arteries, were
precisely obtained and calculated from color duplex ultra-
sound scans, DSA, and CTA before EVSGE, and then the
proper stent-graft complex was selected.
Second, under dynamic supervision of DSA, two cath-
eters were inserted into celiac orifice and SMA orifice,
respectively, through the unilateral femoral artery. After the
double catheters’ simultaneous arteriography, the catheter
in SMA was reserved throughout the deploying procedure
to supervise the SMA dynamically and to prevent it from
being mistakenly occluded.
Finally, the Talent stent-graft complex was reassembled
on table to reverse the orientation marker and the proximal
uncovered stent distally just before deploying. By these
measures, the SMA blood flow was successfully preserved,
even though the distance from the celiac axis orifice to that
of SMA was only 0.5 cm.
Technically we excluded the giant false hepatic-celiac
aneurysm with placement of a stent graft in the abdominal
aorta. But this pseudoaneurysm was an infected lesion, and
traditional experience—including our textbook on vascular
surgery—strongly contraindicates implantation of a pros-
thetic graft in an infected aneurysm. Fortunately, our pro-
cedure did work, and the patient recovered without any
infectious symptoms in the long-term follow-up.
In consultations we have not found any reasonable
explanations for this phenomenon, but we have found
more and more reports on endovascular therapy with pros-
thetic stent grafts for infected aneurysms, and most of them
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this method as the first choice for an infected aneurysm
patient, but for a debilitated high-risk patient who had a
surgery history in the upper abdomen, we considered en-
dovascular therapy a good choice.
In conclusion, the successful endovascular therapy of
this special case implies that covering of the orifice of a giant
aneurysm with a stent graft in the abdominal aorta is an
option, and it also works in infected lesions.
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